Showing 1 - 20 results of 35 for search 'Christos Chouaïd', query time: 0.06s
Refine Results
-
1
-
2
-
3
<i>ROS-1</i> Fusions in Non-Small-Cell Lung Cancer: Evidence to Date by Sébastien Gendarme, Olivier Bylicki, Christos Chouaid, Florian Guisier
Published 2022-01-01
Article -
4
Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: A nationwide study in France by Jonas Poucineau, Jonas Poucineau, Tristan Delory, Tristan Delory, Tristan Delory, Nathanaël Lapidus, Gilles Hejblum, Christos Chouaïd, Christos Chouaïd, Sophie Le Cœur, Myriam Khlat
Published 2022-09-01
Article -
5
Impact of the COVID-19 Pandemic on COPD Patient Mortality: A Nationwide Study in France by Jonas Poucineau, Jonas Poucineau, Myriam Khlat, Nathanaël Lapidus, Nathanaël Lapidus, Nathanaël Lapidus, Maude Espagnacq, Christos Chouaïd, Christos Chouaïd, Tristan Delory, Tristan Delory, Tristan Delory, Sophie Le Coeur
Published 2024-02-01
Article -
6
Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systema... by Sébastien Gendarme, Helene Goussault, Jean-Baptiste Assié, Cherifa Taleb, Christos Chouaïd, Thierry Landre
Published 2021-03-01
Article -
7
Analysis of health economics assessment reports for pharmaceuticals in France – understanding the underlying philosophy of CEESP assessment by Mondher Toumi, Anastasiia Motrunich, Aurélie Millier, Cécile Rémuzat, Christos Chouaid, Bruno Falissard, Samuel Aballéa
Published 2017-01-01
Article -
8
-
9
Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP... by Simon Nannini, Florian Guisier, Hubert Curcio, Charles Ricordel, Pierre Demontrond, Safa Abdallahoui, Seyyid Baloglu, Laurent Greillier, Christos Chouaid, Roland Schott
Published 2024-03-01
Article -
10
-
11
Risk factors for early mortality of lung cancer patients in France: A nationwide analysis by Hélène Goussault, Sébastien Gendarme, Jean‐Baptiste Assié, Camille Jung, Salomé Epaud, Christelle Algans, Noémie Salaun‐Penquer, Mathilde Rousseau, Andrea Lazatti, Christos Chouaïd
Published 2022-12-01
Article -
12
Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study) by Jean-Baptiste Assié, Romain Corre, Matteo Giaj Levra, Christophe Yannick Calvet, Anne-Françoise Gaudin, Valentine Grumberg, Baptiste Jouaneton, François-Emery Cotté, Christos Chouaïd
Published 2020-10-01
Article -
13
Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting by Jean-Baptiste Assié, Christos Chouaïd, Hilario Nunes, Dorothée Reynaud, Anne-Françoise Gaudin, Valentine Grumberg, Ronan Jolivel, Baptiste Jouaneton, François-Emery Cotté, Boris Duchemann
Published 2023-01-01
Article -
14
Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience by Tina Lamy, Bastien Cabarrou, David Planchard, Xavier Quantin, Sophie Schneider, Michael Bringuier, Benjamin Besse, Nicolas Girard, Christos Chouaid, Thomas Filleron, Gaëtane Simon, Capucine Baldini
Published 2021-12-01
Article -
15
Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14) by Isabelle Martel-Lafay, Isabelle Monnet, Audrey Lardy-Cleaud, Serge Danhier, Naji Salem, Olivier Gallocher, Pierre Fournel, Christos Chouaid, Olivier Bylicki, the GFPC 01-14 Investigators
Published 2021-09-01
Article -
16
Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy by Julia Grambow-Velilla, Romain-David Seban, Kader Chouahnia, Jean-Baptiste Assié, Laurence Champion, Nicolas Girard, Gerald Bonardel, Lise Matton, Michael Soussan, Christos Chouaïd, Boris Duchemann
Published 2023-04-01
Article -
17
Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC by Paul Lesueur, Alexandre Escande, Juliette Thariat, Enora Vauléon, Isabelle Monnet, Alexis Cortot, Delphine Lerouge, Serge Danhier, Pascal Dô, Catherine Dubos‐Arvis, Christos Chouaïd, Radj Gervais
Published 2018-11-01
Article -
18
Lung cancer, comorbidities, and medication: the infernal trio by Hélène Pluchart, Hélène Pluchart, Hélène Pluchart, Sébastien Chanoine, Sébastien Chanoine, Sébastien Chanoine, Denis Moro-Sibilot, Denis Moro-Sibilot, Denis Moro-Sibilot, Christos Chouaid, Christos Chouaid, Gil Frey, Julie Villa, Bruno Degano, Bruno Degano, Bruno Degano, Matteo Giaj Levra, Matteo Giaj Levra, Pierrick Bedouch, Pierrick Bedouch, Pierrick Bedouch, Anne-Claire Toffart, Anne-Claire Toffart, Anne-Claire Toffart
Published 2024-02-01
Article -
19
Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects by Sébastien Gendarme, Jean-Claude Pairon, Pascal Andujar, François Laurent, Patrick Brochard, Fleur Delva, Bénédicte Clin, Antoine Gislard, Christophe Paris, Isabelle Thaon, Helene Goussault, Florence Canoui-Poitrine, Christos Chouaïd
Published 2022-08-01
Article -
20
Efficacy of Dabrafenib Plus Trametinib Combination in Patients with <em>BRAF</em> V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019 by Jean-Bernard Auliac, Sophie Bayle, Pascal Do, Gwenaëlle Le Garff, Magali Roa, Lionel Falchero, Eric Huchot, Gilles Quéré, Gaëlle Jeannin, Anne-Cécile Métivier, Joëlle Hobeika, Florian Guisier, Christos Chouaid
Published 2020-12-01
Article